Short answer · Medically reviewed summary · Last updated: 2026-05-08
Degos disease, also known as malignant atrophic papulosis, is a rare vasculopathy characterized by the occlusion of small-to-medium-sized blood vessels leading to tissue infarction. While the exact cause remains unknown, current medical consensus points toward a complex interplay of immune system dysregulation, complement pathway activation, and potential vascular damage that results in the disease's signature skin and organ lesions. What causes Degos disease? The primary mechanism of Degos disease involves a process called obliterative endarteritis, where the lining of the blood vessels becomes inflamed and thickened, eventually cutting off blood flow to the skin and internal organs.
Which are the causes of Degos Disease?
Causes of Degos Disease explained: genetic and environmental factors, reviewed against medical sources, plus patient perspectives.
Degos disease, also known as malignant atrophic papulosis, is a rare vasculopathy characterized by the occlusion of small-to-medium-sized blood vessels leading to tissue infarction. While the exact cause remains unknown, current medical consensus points toward a complex interplay of immune system dysregulation, complement pathway activation, and potential vascular damage that results in the disease's signature skin and organ lesions.
What causes Degos disease?
The primary mechanism of Degos disease involves a process called obliterative endarteritis, where the lining of the blood vessels becomes inflamed and thickened, eventually cutting off blood flow to the skin and internal organs. Research suggests that Degos disease may be an autoimmune condition where the body’s immune system mistakenly attacks the lining of its own blood vessels. Unlike many genetic disorders, no single causative gene has been identified, and it is generally not considered an inherited condition.
Are there known genetic or environmental triggers?
To date, there is no evidence that Degos disease is caused by a specific chromosomal abnormality or a single inherited mutation. Because the condition is so rare, it is difficult to isolate environmental triggers, though some researchers investigate whether viral infections or other external stressors might initiate the immune response in susceptible individuals. The distinction here is important: a cause is the direct biological mechanism, while a risk factor is a variable that might increase the likelihood of the disease manifesting.
What are the current theories on the etiology?
Current research into Degos disease is focused on the following areas:
- Complement System Activation: Studying how the membrane attack complex (MAC) deposits in vessel walls may trigger cell death.
- Autoimmune Markers: Investigating circulating antibodies that may contribute to systemic vascular inflammation.
- Endothelial Dysfunction: Analyzing why the cells lining the blood vessels in Degos disease patients undergo such rapid, localized clotting and atrophy.
Next steps
- Consult a board-certified rheumatologist or dermatologist specializing in vasculitis.
- Connect with the 18 members of the Degos disease community on DiseaseMaps.org to share lived experiences.
- Inquire with your medical team about clinical trials investigating complement-inhibiting therapies.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Malignant atrophic papulosis.
- Orphanet: Malignant atrophic papulosis (Degos disease).
- OMIM (Online Mendelian Inheritance in Man): Entry #124150.
- The Degos Disease Support Network and peer-reviewed literature via PubMed.
